Showing results (2151-2160 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 19, 2013
Pazopanib for the first-line treatment of patients with advanced and/or metastatic renal cell carcinoma : a NICE single technology appraisalMary Kilonzo, Jenni Hislop, Andrew Elders, et al.Pharmacoeconomics|January 19, 2013
Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic reviewMaría Buti, Itziar Oyagüez, Virginia Lozano, et al.Pharmacoeconomics|February 8, 2013
The impact of therapeutic reference pricing on innovation in cardiovascular medicineDesmond Sheridan, Jim AttridgePharmacoeconomics|February 8, 2013
Transatlantic convergence with respect to the fourth hurdle?Joshua CohenPharmacoeconomics|February 28, 2013
Cost effectiveness of antiarrhythmic medications in patients suffering from atrial fibrillationBernd Brüggenjürgen, Stefan Kohler, Nadja Ezzat, et al.Pharmacoeconomics|July 23, 2013
Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspectiveAnthony Bentley, Samantha Gillard, Michael Spino, et al.Pharmacoeconomics|July 24, 2013
Navigating time and uncertainty in health technology appraisal: would a map help?Christopher McCabe, Richard Edlin, Peter HallPharmacoeconomics|March 27, 2013
Temporary authorization for use: does the French patient access programme for unlicensed medicines impact market access after formal licensing?Albane Degrassat-Théas, Pascal Paubel, Olivier Parent de Curzon, et al.Pharmacoeconomics|September 4, 2013
Cost-effectiveness analysis of triple therapy with protease inhibitors in treatment-naive hepatitis C patientsAntonio Blázquez-Pérez, Ramón San Miguel, Javier MarPharmacoeconomics|September 12, 2013
Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerationsWilliam S Weintraub, Leonid Mandel, Sandra A WeissPageof 336